Press Releases

Active Biotech AB Year-end report January - December 2013
February 13, 2014 08:37 (CET)
Active Biotech AB Year-end report January - December 2013
February 13, 2014 08:30 (CET)
Teva and Active Biotech Remain Committed to the Development of NERVENTRA® (laquinimod) for Multiple Sclerosis Following the Negative Opinion from the EMA's CHMP
January 24, 2014 13:13 (CET)
Active Biotech to Present at the 32nd Annual J.P. Morgan Healthcare Conference
January 9, 2014 11:25 (CET)
Active Biotech to Present at the 32nd Annual J.P. Morgan Healthcare Conference
January 9, 2014 11:18 (CET)
Laquinimod CHMP/EMA Opinion
December 20, 2013 13:28 (CET)
Laquinimod CHMP/EMA Opinion
December 20, 2013 13:24 (CET)
Active Biotech to Present at the Jefferies 2013 Global Healthcare Conference
November 14, 2013 08:33 (CET)
Active Biotech to Present at the Jefferies 2013 Global Healthcare Conference
November 14, 2013 08:30 (CET)
Active Biotech's election committee appointed
November 11, 2013 08:33 (CET)